Ecron Acunova Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 42.98 Cr
as on 23-10-2024
- Company Age 20 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 102.69 Cr
as on 23-10-2024
- Satisfied Charges ₹ 44.52 Cr
as on 23-10-2024
- Revenue -41.83%
(FY 2023)
- Profit -804.76%
(FY 2023)
- Ebitda 427.29%
(FY 2023)
- Net Worth 46.91%
(FY 2023)
- Total Assets -23.54%
(FY 2023)
About Ecron Acunova
The Corporate was formerly known as Molecular Cellular Research Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 42.98 Cr.
The company currently has active open charges totaling ₹102.69 Cr. The company has closed loans amounting to ₹44.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ecron Acunova Limited India is Vedamirtham Venkatesan as CFO. Ramesh Gopal, Chella Gowrishankar, and Ayaaz Khan serve as directors at the Company.
- CIN/LLPIN
U73100KA2004PLC035260
- Company No.
035260
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2004
- Date of AGM
14 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ecron Acunova?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayaaz Khan  | Managing Director | 15-May-2017 | Current |
| Vedamirtham Venkatesan | CFO | 13-Feb-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Gopal | Director | 12-Nov-2021 | Current |
| Chella Gowrishankar | Director | 23-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Ecron Acunova.
Ecron Acunova Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.83% decrease. The company also saw a substantial fall in profitability, with a 804.76% decrease in profit. The company's net worth Soared by an impressive increase of 46.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ecron Acunova?
In 2023, Ecron Acunova had a promoter holding of 99.97% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Take Solutions LimitedActive 24 yearsRamesh Gopal, Chella Gowrishankar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2017 | ₹102.69 Cr | Open |
State Bank Of India Creation Date: 28 Jun 2013 | ₹2.00 M | Satisfied |
State Bank Of India Creation Date: 27 Jul 2005 | ₹44.32 Cr | Satisfied |
How Many Employees Work at Ecron Acunova?
Ecron Acunova has a workforce of 152 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ecron Acunova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ecron Acunova's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
